Columbia Bank Raises Stock Holdings in The Allstate Corporation $ALL

Columbia Bank grew its position in The Allstate Corporation (NYSE:ALL) by 3.5% in the 2nd quarter, Holdings Channel.com reports. The fund owned 9,277 shares of the insurance provider’s stock after acquiring an additional 316 shares during the quarter. Columbia Bank’s holdings in Allstate were worth $1,794,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the business. Arlington Trust Co LLC raised its position in Allstate by 261.8% in the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares during the last quarter. Clearstead Trust LLC increased its stake in Allstate by 3,800.0% in the second quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 152 shares during the period. Caitong International Asset Management Co. Ltd raised its holdings in shares of Allstate by 315.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock valued at $33,000 after buying an additional 126 shares during the last quarter. Hilltop National Bank acquired a new stake in shares of Allstate during the second quarter worth about $34,000. Finally, Chilton Capital Management LLC purchased a new position in shares of Allstate during the second quarter worth about $38,000. 76.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on ALL shares. Raymond James Financial restated a “strong-buy” rating and issued a $260.00 price target (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. Jefferies Financial Group upped their price target on Allstate from $254.00 to $255.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. JPMorgan Chase & Co. lifted their price objective on shares of Allstate from $254.00 to $260.00 and gave the company an “overweight” rating in a research report on Thursday, November 6th. Evercore ISI set a $233.00 price objective on shares of Allstate and gave the company an “in-line” rating in a research note on Wednesday, October 1st. Finally, Morgan Stanley upped their price objective on shares of Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $237.64.

Insider Activity

In other news, insider Suren Gupta sold 21,871 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $215.21, for a total transaction of $4,706,857.91. Following the sale, the insider owned 100,646 shares of the company’s stock, valued at $21,660,025.66. The trade was a 17.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last three months, insiders have sold 23,671 shares of company stock worth $5,093,974. 1.70% of the stock is currently owned by company insiders.

Allstate Trading Down 0.8%

NYSE:ALL opened at $212.67 on Tuesday. The Allstate Corporation has a 1 year low of $176.00 and a 1 year high of $215.89. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The stock has a fifty day moving average price of $203.70 and a two-hundred day moving average price of $202.12. The stock has a market capitalization of $55.65 billion, a price-to-earnings ratio of 10.00, a PEG ratio of 0.69 and a beta of 0.35.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, topping analysts’ consensus estimates of $5.48 by $5.69. The business had revenue of $17.26 billion for the quarter, compared to analysts’ expectations of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the company posted $3.91 EPS. As a group, sell-side analysts anticipate that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be issued a $1.00 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. Allstate’s dividend payout ratio (DPR) is 12.95%.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.